Navigation Links
Neuralstem Reports Second Quarter Financial Results and Highlights
Date:8/14/2008

$7,399,027 $7,826,053

LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES

Accounts payable and accrued expenses 936,110 1,016,699

STOCKHOLDERS' EQUITY

Preferred stock - -

Common stock 321,513 314,106

Additional paid-in capital 57,029,525 52,151,245

Accumulated deficit (50,888,121) (45,655,997)

Total stockholders' equity 6,462,917 6,809,354

Total liabilities and stockholders' equity $7,399,027 $7,826,053

About Neuralstem

Neuralstem's patented technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells into mature, physiologically relevant human neurons and glia.

Major Central Nervous System diseases targeted by the Company with research programs currently underway include: Ischemic Paraplegia, Traumatic Spinal Cord Injury and ALS. The company's cells have extended the life of rats with ALS (Lou Gehrig's disease) as reported the journal TRANSPLANTATION, in collaboration with Johns Hopkins University researchers, and also reversed paralysis in rats with Ischemic Spastic Paraplegia, as reported in NEUROSCIENCE on June 29, 2007, in collaboration with researchers at University of California San Diego. The Company expects to file its first IND (Investigational New Drug) application with the FDA for ALS in the fall.

Cautionary Statement Regarding Forward Looking Information

This news release may contain forward-looking statements made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements in this press release regarding potential ap
'/>"/>

SOURCE Neuralstem Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Neuralstem Fills Key Product Development Position
2. Neuralstem Responds to New StemCells, Inc. Lawsuit
3. Neuralstem Sues StemCells, Inc. Over New Patent
4. Neuralstem Inc. Announces Strategic Investment by Korean CJ CheilJedang Corporation
5. Patent Office Rules in Neuralstems Favor in Dispute with StemCells, Inc.
6. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.
7. Neuralstem Shares Accepted for Trading on Amex(R)
8. Nile Therapeutics, Inc. Reports 2008 Second Quarter Financial Results
9. Pressure BioSciences, Inc. Reports Second Quarter 2008 Financial Results and Provides Business Update
10. China-Biotics, Inc. Reports First Quarter 2009 Financial Results
11. Senetek PLC Reports Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Aug. 28, 2015 /PRNewswire/ - RepliCel Life Sciences ... medicine company focused on the development of autologous ... quarter ended June 30, 2015, corporate highlights, and ... report are available at www.sedar.com ,  ... "RepliCel expects to launch its RCS-01 ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... Wade McKenna, DO, announced today that the use of sterile, dehydrated amniotic tissue ... healing of an otherwise non-healing surgical knee wound. , The case involved a ...
(Date:8/28/2015)... ... 28, 2015 , ... Since the initial launch of FireflySci Inc. (FFS) in early 2015, the ... service. Images such as the Fonz in a lab coat and Large Marge have ... humdrum spectroscopy field. , FireflySci is proud to be the only cuvette manufacturer ...
(Date:8/27/2015)... ... 27, 2015 , ... The Kansas City Animal Health Investment ... health companies to hear from animal health companies with the newest technology. Companies ... agreements or distribution contracts. This meeting is one of the only investment ...
Breaking Biology Technology:RepliCel Reports Second Quarter 2015 Financial Results 2RepliCel Reports Second Quarter 2015 Financial Results 3RepliCel Reports Second Quarter 2015 Financial Results 4RepliCel Reports Second Quarter 2015 Financial Results 5Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 2Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 3Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 4Cuvette Manufacturer FireflySci Launches Back to School Deals with Complimentary Shipping On All Orders 2VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 2VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 3
... and REHOVOT, Israel, Nov. 4, 2011 Rosetta Genomics, ... and provider of microRNA-based molecular diagnostics, announces that results ... of Oncology, Davidoff Center, Rabin Medical Center, Beilinson Hospital ... post-resection gastric cancer patients microRNAs may serve to predict ...
... SAN DIEGO, Nov. 3, 2011 Sequenom, Inc. (NASDAQ: ... today reported total revenues of $13.6 million for the third quarter ... million for the third quarter of 2010.  Net loss for the ... as compared to net loss of $22.7 million, or $0.30 per ...
... Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ... and gastroenterology markets, today announced third quarter 2011 financial results. ... ended September 30, 2011, net revenue was $13.1 million, up ... in net revenue was driven by an increase in sales ...
Cached Biology Technology:Study Published in World Journal of Gastroenterology Shows Potential for microRNAs to Predict Gastric Cancer Recurrence 2Study Published in World Journal of Gastroenterology Shows Potential for microRNAs to Predict Gastric Cancer Recurrence 3Study Published in World Journal of Gastroenterology Shows Potential for microRNAs to Predict Gastric Cancer Recurrence 4Study Published in World Journal of Gastroenterology Shows Potential for microRNAs to Predict Gastric Cancer Recurrence 5Study Published in World Journal of Gastroenterology Shows Potential for microRNAs to Predict Gastric Cancer Recurrence 6Sequenom, Inc. Reports Financial Results for the Third Quarter of 2011 2Sequenom, Inc. Reports Financial Results for the Third Quarter of 2011 3Sequenom, Inc. Reports Financial Results for the Third Quarter of 2011 4Sequenom, Inc. Reports Financial Results for the Third Quarter of 2011 5Sequenom, Inc. Reports Financial Results for the Third Quarter of 2011 6Sequenom, Inc. Reports Financial Results for the Third Quarter of 2011 7Sequenom, Inc. Reports Financial Results for the Third Quarter of 2011 8Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 2Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 3Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 4Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 5Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 6Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 7Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 8Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 9Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 10Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 11Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results 12
(Date:8/28/2015)... 28, 2015 According to a ... by Assessment Type (Pen & Paper Based, Hosted, Biometrics), ... Learning, Academic Research), Vertical and Region - Global Forecast ... Market to grow from USD 2.4 Billion in 2015 ... Annual Growth Rate (CAGR) of 25.6% from 2015 to ...
(Date:8/26/2015)... 2015 The report "Multi-Factor Authentication (MFA) ... Application (Travel & Immigration, Government, Banking, Defense, Commercial Security, ... 2020", published by MarketsandMarkets, Multi-Factor Authentication Market is expected ... a CAGR of 17.7% between 2015 and 2020. ... igures spread through 169 P ages ...
(Date:8/25/2015)... and BELLEVUE, Wash. , Aug. 25, ... robotic systems, announced today it will unveil its "Guardian ... (UGV), at the National Tactical Officers Association Conference on ... The Guardian S is the first-ever commercially available energetically ... of research and in-field trials and is protected by ...
Breaking Biology News(10 mins):Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 2Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 3Cognitive Assessment and Training Market Worth 7.5 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3
... Scientists report they have "compelling evidence" that the ... Their study, published today in the journal Proceedings ... of the Deepwater Horizon oil spill on a deep-water ... wide range of underwater vehicles, including the submarine Alvin, ...
... Intensive research around the world has focused on improving the ... But very little attention has been paid to the best ... on a rooftop or other surface, or sometimes attached to ... as it crosses the sky. Now, a team of ...
... launches its Centre for Carbon Measurement, which will ... modelling, global carbon markets and green technology. Business ... potential to reduce emissions and stimulate the economy. ... policies to meet emissions reduction targets through clean ...
Cached Biology News:Study by Haverford College professor reveals unprecedented impact of Deepwater Horizon on deep ocean 2Study by Haverford College professor reveals unprecedented impact of Deepwater Horizon on deep ocean 3Study by Haverford College professor reveals unprecedented impact of Deepwater Horizon on deep ocean 4A new dimension for solar energy 2A new dimension for solar energy 3New Center for Carbon Measurement to drive UK's low carbon economy 2New Center for Carbon Measurement to drive UK's low carbon economy 3
2,4,6, Trinitrophenyl hapten is conjugated to lipopolysaccharide (LPS)....
For the quantitative determination of cyclic AMP (cAMP) concentrations in cell culture supernates, serum, plasma, saliva, urine and cell lysates....
... the Flp-In System creates isogenic cell ... levels of the protein of interest. ... Figure 3 (click link below). In ... chloramphenicol-acetyl transferase (CAT) was subcloned into ...
... solvents can be used, such as water, benzene, formamide, nitrobenzene, cyclohexane, 1,4-dioxane, p-xylene, dimethyl sulfoxide, freon ... * Range: 12-position switchable: ... ... ...
Biology Products: